Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

Proteome Podcasts

show episodes
 
Artwork
 
Proteomics in Proximity discusses the intersection of proteomics with genomics for drug target discovery, the application of proteomics to reveal disease biomarkers, and current trends in using proteomics to unlock biological mechanisms. Co-hosted by Olink's Dale Yuzuki, Cindy Lawley and Sarantis Chlamydas.
  continue reading
 
Artwork

1
Speaking of Mol Bio

Thermo Fisher Scientific

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Speaking of Mol Bio, a podcast series from Thermo Fisher Scientific, discusses trending applications in science and the molecular biology aspects of those applications. Our host delves in to deep discussion with CEOs, R&D scientists, researchers, and key opinion leaders across the globe. Speaking of Mol Bio helps scientific curious people - from all scientific and non-scientific backgrounds - understand how modern molecular biology applications can help push the boundaries in medicine, scien ...
  continue reading
 
Artwork

1
Translating Proteomics

Nautilus Biotechnology

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
‘Translating Proteomics’ explores the science of proteomics and its growing impact on biological research, biomarker discovery, drug development, food and energy security, and a range of other timely topics. Hosts Parag Mallick Ph.D. and Andreas Huhmer Ph.D. of Nautilus Biotechnology aim to share their perspectives on important issues in proteomics, deepen your love of science, and prompt you to question assumptions about what may be possible.
  continue reading
 
Artwork
 
The PROTEOMICS podcast is a free audio show featuring top articles from PROTEOMICS (www.proteomics-journal.com), one of the key journals in proteomic research. Listen every month to interviews with leading scientists around the world to open up the fascinating world of proteomics through their ideas and research. Get to know the PROTEOMICS family with the new addition to the podcast featuring Clinical Applications, providing insight into the application of proteomics to the study of human di ...
  continue reading
 
Artwork

1
Personalized Medicine Podcast

Oleksandr Yagensky

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
On this podcast leading scientist, clinicians and entrepreneurs share their thoughts on the progress of personalized medicine. With our guests, we discuss new technologies for targeted treatments and diagnostics, their benefits for patients and clinicians and related implementation challenges.
  continue reading
 
Artwork

1
Clinical Chemistry Podcast

Association for Diagnostics and Laboratory Medicine

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Weekly
 
This free monthly podcast is offered by Clinical Chemistry. Clinical Chemistry is the leading forum for peer-reviewed, original research on innovative practices in today's clinical laboratory.
  continue reading
 
Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.
  continue reading
 
Artwork

1
Preprints in Motion

Dr Jonny Coates, Rippling Ideas

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Science is experiencing a revolution. Preprints have accelerated the sharing of scientific findings and helped to make academia more equitable. Join our host, immunologist and open-science advocate, Dr Jonny Coates, as he explores the freshest science with the early career researchers who did the work; discussing their science, thoughts on academic life, publishing and much more. So sit back and join us as we dive into the fast-paced world of preprints and dismantle the outdated traditional ...
  continue reading
 
A fascinating, informative and digestible podcast highlighting the rich and diverse neuroscience published in the Brain journals. The episodes will take the format of interviews with article authors and the aim is to produce an informal and enjoyable podcast that appeals to a broad audience including clinicians, researchers, students, neuroscientists, neurologists, neurosurgeons and psychiatrists
  continue reading
 
Artwork
 
Welcome to Talking Techniques! In this Podcast BioTechniques Digital Editor Tristan Free, interviews researchers at the forefront of their fields about the latest breakthroughs, controversies and conversations in the life sciences. From CRISPR to COVID-19, organoids to the microbiome, this podcast will explore the latest developments in the lab and interesting applications of techniques, while trying to determine how we can drive science forward in progressive and inventive ways. Hosted on A ...
  continue reading
 
Artwork

1
mAcademia - Science, More than Just Academia.

Elena Itskovich & Ofer Yizhar Barnea

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
After spending time in academia and exploring the unknown, the industry often seems too limited scientifically to those finishing a PhD. We will explore the bridge between the industry and academia to understand how basic scientific findings take shape into products and strategies. We will also follow the career paths of researchers who are in academia or outside of it, professionals that made their choice, followed it through and come to us to tell all about it. Academia or not? And if not, ...
  continue reading
 
Loading …
show series
 
Welcome to the Olink® Proteomics in Proximity podcast! Below are some useful resources mentioned in this episode: Olink tools and software · Olink® Explore HT, Olink’s most advanced solution for high-throughput biomarker discovery, measuring 5400+ proteins simultaneously with a streamlined workflow and industry-leading specificity: https://olink.co…
  continue reading
 
In this Mol Bio Minutes episode, Dr. Will Barnes, a plant biologist turned senior sales training specialist at Thermo Fisher Scientific, reflects on his time at the bench and the molecular lessons learned along the way. Will dives deep into the difficulties of RNA work in plant systems—carbohydrate contamination, genomic DNA carryover, secondary st…
  continue reading
 
In this episode of From the Helm, Grady Wulff sits down with Sports Entertainment Group (ASX:SEG) CEO Craig Hutchison and CFO Trent Bond to unpack the company’s strong FY25 results, its multi-platform content strategy, and growth outlook heading into FY26. Craig and Trent share insights into SEG’s radio and non-radio pillars, the company’s recent R…
  continue reading
 
This week we discuss ant head shapes and evolution with Cristian L. Klunk, a Post-doc in Germany. Read the full preprint -> https://www.biorxiv.org/content/10.1101/2025.03.19.643247v1 This episode was produced by Sonia Gomes Pereira and edited by Sonia Gomes Pereira. Music by Dr John D Howard. Submit your question that you’d like us to via our webs…
  continue reading
 
In this episode of From the Helm, Grady Wulff sits down with Cynata Therapeutics (ASX:CYP) CEO, Kilian Kelly, to discuss the company’s pioneering work in stem cell and regenerative medicine. Kilian shares insights on Cynata’s mesenchymal stromal cell (MSC) platform, its unique “one donor, one time” approach, the path to commercialisation, and what …
  continue reading
 
In this episode of From the helm, Grady Wulff sits down with Grant Nichols, Centuria Head of Listed Funds and CIP Fund Manager, and Belinda Cheung, COF Fund Manager, to discuss sector tailwinds driving investor appetite across industrial and office real estate as FY26 kicks off. Grant shares his outlook for the industrial sector amid resilient dema…
  continue reading
 
In this episode of From the Helm, Senior Market Analyst Grady Wulff sits down with Raymond van Hulst, CEO of Omni Bridgeway (ASX:OBL) to discuss what is a unique diversification opportunity for investors in the legal space. Raymond dives into who Omni Bridgeway are, why investors should consider investment into the company, their recently released …
  continue reading
 
In this episode of From the helm, Grady Wulff sits down with Electro Optic Systems (ASX:EOS) CEO, Andreas Schwer to unpack the company’s recent share price momentum, global expansion strategy, and breakthrough technology in the defence sector. Andreas shares insights into EOS’s contract pipeline, advancements in high-energy laser systems, and what …
  continue reading
 
Dr. Iyad Alnahhas interviews Drs. Felix Sahm and Maximilian Deng about their recent manuscript entitled: "Postoperative radiotherapy in subtotally-resected recurrent WHO grade 1 meningiomas with intermediate/ high-risk molecular profiles", published online in Neuro-Oncology in May 2025.By Drs. Felix Sahm, Maximilian Deng, Iyad Alnahhas
  continue reading
 
In this episode of Speaking of Mol Bio, host Steve Lewis speaks with Dr. Melissa Wu, co-founder and CEO of Seeding Labs, a nonprofit that’s redefining global scientific access. Dr. Wu shares the inspiring story of how Seeding Labs helps institutions in developing nations build research infrastructure by redistributing surplus laboratory equipment f…
  continue reading
 
If you enjoyed this show then hit that subscribe button and leave a review (on Apple Podcasts or Spotify). If you love what we are trying to do then buy us a coffee https://www.buymeacoffee.com/preprints! Any contribution is greatly appreciated. For the latest podcast news and updates follow us on Instagram @Motion_Pod or visit our website; www.pre…
  continue reading
 
Dr. Maya Graham interviews Dr. Jessica Foster about her and her team's recent manuscript, entitled "Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high-grade glioma models". This work was published online in Neuro-Oncology in May 2025.By Drs Maya Graham, Jessica Foster, Iyad Alnahhas
  continue reading
 
As part of the US HUPO sponsored "Alt Proteomics" series highlighting alternative proteomics things, Ben and Ben sit down to talk with Chef Michael Toscano of Le Farfalle (Charleston, SC), da Toscano (NYC), Porchetta Shop (Charleston, SC), Fugazzi at Revelry Brewing (Charleston, SC), 3's Golf (Greenville, SC), and Blanca Estrada Taqueria (Charlesto…
  continue reading
 
In this episode of From the helm, Grady Wulff sits down with Infratil (ASX:IFT) CEO Jason Boyes to discuss the company’s global infrastructure portfolio, spanning renewables, data centres, healthcare and more. Jason shares insights on Infratil’s long-term returns, key growth thematics, and what investors can expect in the year ahead. In this interv…
  continue reading
 
Science is under attack, particularly in the USA where the current Trump administration has been systematically destroying scientific and academic institutions, attacking science and scientists, spreading disinformation and conspiracy theories and hijacking open science principles to justify these actions. We spoke with Philip Cohen to discuss the …
  continue reading
 
In this Mol Bio Minutes mini-episode, Thermo Fisher Scientific’s Agnė Žiupkaitė takes listeners on a journey through the evolving world of RNA assay development—focusing specifically on 1-Step RT-qPCR. She outlines the critical considerations for assay developers, including enzyme speed, robustness, and the growing demand for customizable reagents …
  continue reading
 
Welcome to the 29th episode of The Brain Podcast - the official podcast of the journals Brain and Brain Communications. This episode features a discussion with first author of the Brain article entitled: Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis We are joined by Alida Chen for an interesting…
  continue reading
 
Many of us grew up with the scent of Johnson's Baby Powder as one of our earliest memories. Trusted by moms since 1894, the product has built an extraordinary trusted brand (rooted in deep scent associations with motherly love) for one of the world's largest pharmaceutical companies, Johnson and Johnson. But in 2018 Reuters published an investigati…
  continue reading
 
In this episode, host Steve Lewis sits down with Giovanna Prout, President and CEO of Scale Biosciences, to explore how Scale is pushing the boundaries of single-cell omics. With a career that spans roles with big players and entrepreneurial ventures, Giovanna brings a unique perspective to the world of genomics innovation. Giovanna dives into Scal…
  continue reading
 
In this episode of From the Helm, Bell Financial Group’s Grady Wulff sits down with Yojee (ASX:YOJ) CEO, Mark Connell, to discuss how the company is harnessing artificial intelligence and machine learning to lead innovation in logistics software. With shares climbing over the past year, Mark shares what’s driving growth and where Yojee is headed ne…
  continue reading
 
In this episode of Speaking of Mol Bio, Aistė Serapinaite, an experienced R&D scientist, shares her insights into the world of 1-Step RT-PCR—a method that simplifies RNA analysis by combining reverse transcription and PCR amplification in a single reaction. She explains how traditional RNA workflows once lengthy, multi-step processes were prone to …
  continue reading
 
In this episode of From the Helm, Bell Financial Group’s Grady Wulff speaks with DroneShield (ASX: DRO) CEO, Oleg Vornik, about the company’s rapid momentum in FY25, key contract wins, and how it’s positioned as a leader in counter-drone technology amid heightened global defence spending. In this video, Oleg covers: • (0:58): FY25 momentum and majo…
  continue reading
 
Join us for a tactical deep dive into the Defence sector in this special episode of our 2025 Meet the Analyst series. Bell Direct’s Senior Market Analyst, Grady Wulff, sits down with Bell Potter Industrials Analyst, Daniel Laing, to explore one of the market’s most talked-about themes, defence stocks. From unpacking global defence spending trends t…
  continue reading
 
This week we discuss the regulation of spermatogenesis and the strength of a of wet/dry lab combo with Rion Brattig-Correia and Joana M. Almeida, a Senior Data Science Manager at NielsenIQ (Rion) and a PhD Student (Joana). Read the full work -> https://elifesciences.org/articles/95774 This episode was produced by Sonia Gomes Pereira and edited by S…
  continue reading
 
On this episode of Translating Proteomics, Parag, Andreas, and special guest Don Kirkpatrick answer questions submitted by the Translating Proteomics community. They cover: Needs in plasma proteomics How proteomics impacts drug development – with special guest Don Kirkpatrick, Ph.D.! How lifestyle impacts the proteome How the Nautilus Proteome Anal…
  continue reading
 
Dr. Evan Noch interviews Dr. Akshitkumar Mistry about his and his team's recent manuscript entitled "A clinically annotated transcriptomic atlas of nervous system tumors", published online in Neuro-Oncology in May 2025 Link to the paper: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noaf130/8151442…
  continue reading
 
As part of the US HUPO sponsored "Alt Proteomics" series highlighting alternative proteomics things, Ben and Ben sit down to talk with Dr. Aleksei Aksimentiev, University of Illinois at Urbana-Champaign. (Elevator music by Mykola Odnoro from Pixabay. We had some tech issues and lost about 2 minutes... so be glad our professional editor didn't fill …
  continue reading
 
In this episode of Speaking of Mol Bio, Dr. Beth Webb takes us deep into the world of platelets, often misunderstood components of blood that punch far above their weight in both physiological and pathological processes. As a postdoctoral researcher at the University of Leeds, Dr. Webb explores how endothelial signals influence platelet activity, a…
  continue reading
 
In this episode of From the helm, Bell Financial Group’s Grady Wulff speaks with Proteomics International Laboratories (ASX: PIQ) CEO, Dr. Richard Lipscombe, about the company’s ground breaking work in predictive diagnostics and the global opportunity for its world-first blood tests. In this video, Dr. Lipscombe covers: · (0:47): An overview of PIQ…
  continue reading
 
In this episode of From the Helm, Bell Financial Group’s Grady Wulff speaks with Perseus Mining (ASX: PRU) CEO, Jeff Quartermaine, about the company’s strategic direction, growth projects across West Africa, and how it’s positioned amid a booming gold market. In this video, Jeff covers: • (0:37): how current gold market tailwinds are shaping its su…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play